Senior Health Economist
- Research & Development
- Denmark - Søborg
Health economics is an important part of obtaining market access for our products. A key challenge for the pharmaceutical industry is to get the healthcare decision makers to support funding of innovative medicines. This requires a strong health economic evidence package to support our future product launches which you will take part in establishing.
About the department
Our goal is to generate and document scientific information related to health economics and outcomes research (HEOR) that further increases the value of Novo Nordisk products in addition to quality, safety and efficacy.
HE&HTA aims to bridge commercial aspiration with sound scientific evidence, by providing output that will enable Novo Nordisk to achieve patient access to our products at an optimal price. This involves economic modelling, database studies, patient-reported outcomes (PRO), and HEOR input to clinical trial design.
The job
We are offering a global role that involves a wide range of interesting and challenging assignments, which are related to demonstrating value of our pipeline portfolio. You will be accountable for managing and implementing the HEOR perspective into the Novo Nordisk drug pipeline. It involves strategy-setting and execution of HEOR projects such as cost-effectiveness analyses, willingness-to-pay studies etc. In addition, you will be responsible for health economic and PRO input to overall clinical development plans and individual trials. The position requires being up to date on health technology assessment (HTA) trends and requirements.
The candidate we are looking for will be working to support Novo Nordisk’s future haemophilia products currently in clinical development.
You will liaise across functions on pricing/reimbursement, HTA and clinical requirements. Therefore superior stakeholder management skills and the ability to communicate technical results in a non-technical way are essential to be successful in this position.
Qualifications
The position requires a Master or Ph.D. degree in Health Economics, Economics, Public Health, pharmacy or another related area.
It is vital that you have a strong scientific background and the ideal candidate will have gained relevant experience in HEOR/PRO. Relevant experience includes pharmaceutical industry, consultancy and relevant government bodies.
You need to be collaborative and have excellent interpersonal skills. The ability to manage a diverse set of stakeholders and handle projects in a team-oriented/cross-functional environment is key to success. It is important that you are business-oriented, enjoy responsibility and are able to manage working independently, under pressure and within timelines. Furthermore, you need to be a good communicator. Fluency in English is a requirement, as you will work in a global environment with contacts all over the world. International travel will be necessary on occasion as well.
At Novo Nordisk, your skills, dedication and ambition help us change lives for the better. In exchange, we offer you an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development.
Contact
For further information, please contact Mark Aagrenat +45 3079 9976 or Anne Kirstine Busk at +45 3079 9449.
Deadline
30 August 2013.
- Research & Development
- Denmark - Søborg
Health economics is an important part of obtaining market access for our products. A key challenge for the pharmaceutical industry is to get the healthcare decision makers to support funding of innovative medicines. This requires a strong health economic evidence package to support our future product launches which you will take part in establishing.
About the department
Our goal is to generate and document scientific information related to health economics and outcomes research (HEOR) that further increases the value of Novo Nordisk products in addition to quality, safety and efficacy.
HE&HTA aims to bridge commercial aspiration with sound scientific evidence, by providing output that will enable Novo Nordisk to achieve patient access to our products at an optimal price. This involves economic modelling, database studies, patient-reported outcomes (PRO), and HEOR input to clinical trial design.
The job
We are offering a global role that involves a wide range of interesting and challenging assignments, which are related to demonstrating value of our pipeline portfolio. You will be accountable for managing and implementing the HEOR perspective into the Novo Nordisk drug pipeline. It involves strategy-setting and execution of HEOR projects such as cost-effectiveness analyses, willingness-to-pay studies etc. In addition, you will be responsible for health economic and PRO input to overall clinical development plans and individual trials. The position requires being up to date on health technology assessment (HTA) trends and requirements.
The candidate we are looking for will be working to support Novo Nordisk’s future haemophilia products currently in clinical development.
You will liaise across functions on pricing/reimbursement, HTA and clinical requirements. Therefore superior stakeholder management skills and the ability to communicate technical results in a non-technical way are essential to be successful in this position.
Qualifications
The position requires a Master or Ph.D. degree in Health Economics, Economics, Public Health, pharmacy or another related area.
It is vital that you have a strong scientific background and the ideal candidate will have gained relevant experience in HEOR/PRO. Relevant experience includes pharmaceutical industry, consultancy and relevant government bodies.
You need to be collaborative and have excellent interpersonal skills. The ability to manage a diverse set of stakeholders and handle projects in a team-oriented/cross-functional environment is key to success. It is important that you are business-oriented, enjoy responsibility and are able to manage working independently, under pressure and within timelines. Furthermore, you need to be a good communicator. Fluency in English is a requirement, as you will work in a global environment with contacts all over the world. International travel will be necessary on occasion as well.
At Novo Nordisk, your skills, dedication and ambition help us change lives for the better. In exchange, we offer you an opportunity to work with extraordinary talent and benefit from a range of possibilities for professional and personal development.
Contact
For further information, please contact Mark Aagrenat +45 3079 9976 or Anne Kirstine Busk at +45 3079 9449.
Deadline
30 August 2013.